Quantcast

Posts related to ‘Pharmaceuticals’

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Posted: December 8, 2011 at 11:14 am

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks and months ahead.  Among those we expect to raise the ...
Read Full Story »

Probing for Value in Big Pharmaceutical Stocks (JNJ, PFE, AZN, BMY, MRK)

Posted: November 21, 2011 at 1:47 pm

It now costs about $1 billion to get a new drug to market, or, if a company is unlucky, $1 billion to fail to get the drug to market. Like ...
Read Full Story »

Dendreon Buyout, How Imminent?

Posted: November 17, 2011 at 1:45 pm

Though near-term growth visibility for its cancer vaccine Provenge remains cloudy, Seattle-based Dendreon (DNDN) could be an attractive takeover candidate – especially to a major pharmaceutical house seeking a unique ...
Read Full Story »

America’s Psychiatric Drug Addition

Posted: November 16, 2011 at 6:24 am

“Sell crazy someplace else; we’re all stocked up here,” says Jack Nicholson in 1997’s As Good as It Gets. There was a point, not so many years ago, when Prozac ...
Read Full Story »

The Eight Drug Shortages Putting Americans at Risk

Posted: November 5, 2011 at 11:07 am

President Obama this week signed an executive order directing federal regulators to address shortages of vital prescription drugs. According to the president, the order, which does not need congressional approval, ...
Read Full Story »

Economics of Painkiller Abuse

Posted: November 2, 2011 at 6:19 am

The regions of the U.S. in which painkiller use is extremely high also tend to be the poorest sections of the nation. Some of the reasons for this are not ...
Read Full Story »

Novartis Cuts 2,000 as Pharma Industry Continues to Falter

Posted: October 25, 2011 at 6:24 am

Novartis (NYSE: NVS) said it would cut 2,000 workers and outsource some functions to companies that will do the work for less than it can. Novartis will take a restructuring ...
Read Full Story »

Lilly’s Drugs Closer to Edge of Patent Cliff (LLY, PFE, JNJ, BMY, SNY, MRK)

Posted: October 20, 2011 at 10:58 am

Drug maker Eli Lilly & Co. (NYSE: LLY) reported third-quarter earnings this morning, and the company did a little better than analysts expected, but worries persist that the company will ...
Read Full Story »

The Abbott Break-Up Seems To Make Sense (ABT, BIIB, BMY)

Posted: October 19, 2011 at 10:18 am

Drug and medical stocks are not generally thought of as stocks hitting 52-week highs by the investing public.  So what about when a company decides to unlock shareholder value by ...
Read Full Story »

Expected Upside Gains for Leading Pharmaceutical Companies (JNJ, PFE, AZN, BMY, MRK)

Posted: October 12, 2011 at 2:10 pm

Sales for the big pharmaceutical companies are expected to be hit by pricing pressure in Europe, a lack of urgent new on the coming flu season, lower rates of prescription ...
Read Full Story »

More Than Promising Results for New Heart Drug (BMY, PFE, JNJ, BAYRY, DSKYY, PPH)

Posted: August 29, 2011 at 12:39 pm

A new heart drug aimed a reducing the risk of strokes has outperformed the current drug of choice, warfarin, in a study that shows it lowers risk from a type ...
Read Full Story »

Picking Apart the Dendreon Implosion (DNDN)

Posted: August 4, 2011 at 7:59 am

Dendreon Corporation (NASDAQ: DNDN) was supposed to be the Holy Grail when it comes to investing in a treatment for prostate cancer.  The limited life-extension versus a high cost for ...
Read Full Story »

Pharma Earnings Winner: Pfizer Versus Merck (MRK, PFE, LLY)

Posted: August 2, 2011 at 10:01 am

Merck & Co. Inc. (NYSE: MRK) released second-quarter results last Friday and Pfizer Inc. (NYSE: PFE) reported this morning.  The results of both drug behemoths are largely in line with ...
Read Full Story »

National Employee Morale Day At Merck (MRK)

Posted: July 30, 2011 at 8:14 am

Merck (NYSE: MRK) released an unusual earnings announcement. It is profitable, has a bright future, and will fire about 13,000 people. These employees can leave with the knowledge that they ...
Read Full Story »

Beyond the Pharma Patent Cliff, Dividends Galore (LLY, BMY, MRK, PFE, ABT)

Posted: June 16, 2011 at 8:10 am

Many drug companies face a what is called a patent cliff ahead, where the Big Pharma players will have key drugs go off-patent and there will be new generic competition.  ...
Read Full Story »